Optical Q™ Fluorescence Immunoassay Analyzer

Quantitative in-vitro FIA rapid diagnostic POCT analyzer

Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Brand name
Optical Q
Payment Terms
Production method
Shipping / Lead Time
Negotiable / Negotiable
diagnostic devices, ivd, poct, fluorescence immunoassay,
Other Monitoring & Diagnostic Equipment

OptiBio Co., Ltd.

Recent Visit
Nov 30, 2022
Country / Year Established
South Korea South Korea / 2019
Business type
Product name Optical Q™ Fluorescence Immunoassay Analyzer Certification -
Category Other Monitoring & Diagnostic Equipment Material -
Keyword diagnostic devices , ivd , poct , fluorescence immunoassay Unit Size -
Brand name Optical Q Unit Weigh 4 kg
origin South Korea Stock 10000
Supply type OBM HS code 9027

Product Information


Optical Q™ is a cutting edge in vitro diagnostics (IVD) fluorescence immunoassay (FIA) point of care (POCT) analyzer that accurately measures the concentration of analytes contained in blood, serum, plasma, and other samples. Results are generated within a prompt 15 minute time frame with CV's ranging from 5%~10%.


In contrast to standard FIA analyzers that use gold nano particles, Optical Q utilizes highly sensitive fluorescent material and incorporates world class lens technology to not only test for the presence of a disease but also accurately quantify the concentration or severity of the disease. 


In addition, Optical Q features a wide variety of diagnostic marker - many of which are developed in house that covers health categories including but not limited to inflammation, infection, diabetes, vitamin D deficiency, thyroids, and more. Our capacity to develop our device and antibodies in house enables optimized performance against competitors. 


Optical Q is truly a rapid one-stop diagnostic solution.


Optical Q™ features 24 parameters / reagents as seen below: 


Inflammation: CRP, PCT                                                                                           


Tumor: AFP, CEA, PSA                                                                                            


Hormone: beta-hCG, LH, FSH, PRL, Cortisol, Testosterone, Progesterone


Thyroid: TSH, Total T3, Free T3, Total T4, Free T4                                              


Cardiac: Myoglobin, CK-MB, D-Dimer, NT-proBNP                                           


Diabetes: HbA1c                                                                                                     


Others: Ferritin                                                                                                        


COVID-19: Neutralizing antibody (nAb).


Technical Highlights


Performance• Instant results within 3~15 minutes
• High CV performance <10%
• 24 test parameters and expanding
• 3 step process: dilute, drop, analyze
• Portable weight and size
• Modifiable tests
Technology• Top optical lens resolution F/N 1
• RFID for test and lot identification
• Internal printer for results




Test Method
Quantitative Fluorescence Immunoassay
Dimensions357 mm (L) x 284 mm (W) x 156 mm (H)
3.5 kg
Power Supply
DC 12V/5A, AC/DC Adaptor
Data OutputLCD / Internal printer
99 patient results
RS422 (RJ45) / mini 5pin / USB
Display LCD
5”Mono LCD
Working ConditionTemperature: 15-30°C / Humidity: 10-70%


Cat No.DescriptionPacking SizeStorage Condition
OB001Optical Q Analyzer2 Unit/CartonRoom Temperature


B2B Trade

Price (FOB) Negotiable transportation Air Transportation,Negotiation Other
MOQ Negotiable Leadtime Negotiable
Payment Options T/T Shipping time Negotiable

OptiBio Co., Ltd.

Country / Year Established
South Korea South Korea / 2019
Recent Visit
Nov 30, 2022
Business type
Jeawon Kim, Minyoung Choi
Bonbukwan-401, 76, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Korea
Product Category
Other Monitoring & Diagnostic Equipment
Year Established
Company introduction

OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.

OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.

Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs.

OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.

Main Markets

Brazil Brazil

Germany Germany

Ethiopia Ethiopia

Mexico Mexico

Nigeria Nigeria

Main Product
Attached File

Related Products

Other buyers also search

Membership Grade


Biz Pro VIP


Biz Pro VIP
Live Chat

No Data

  • There is no data to load
  • Check out the My tK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more